4:01 PM ET
Form 4
Insider Selling
Fate Therapeutics CFO Kamal Adawi Sells $13.5K of Stock
Kamal Adawi, CFO, sold 6,582 shares of Fate Therapeutics Inc at $2.05 a share, worth $13.5K in total on Nov 3, 2026. Shares held after the trade: 93,418 (-6.6%).
- Value
- $13.5K
- Shares
- 6,582
- Price
- $2.05
- Role
- CFO
- Holding change
- -6.6%
- Trade date
- Nov 3, 2026